I previously wrote an article about data bias against women and what I learned from reading Caroline Criado-Perez’s book Invisible Women: Exposing Data Bias in a World Designed for Men. In this article I wanted to focus on the impacts of data bias against women specifically in healthcare. In the era of advancing technology and data-driven decision-making, we cannot ignore the critical role data plays in shaping healthcare policies and treatment strategies. However, a darker reality lurks beneath the surface as data bias against women becomes increasingly apparent in the healthcare sector. This bias not only impacts the accuracy of diagnoses and treatment plans but also perpetuates gender-based disparities in medical research and outcomes.

Historically, medical research has predominantly focused on male subjects, leading to a significant gender gap in health data. Clinical trials, drug studies, and even basic research often exclude or do not sufficiently represent women, resulting in a skewed understanding of health conditions and responses to treatments. Often, women are not represented in data collection because of the so-called “unreliable” cycle of hormones. But instead of ignoring this, professionals must design medications which work with female hormonal cycles. This omission has serious consequences as women may react differently to medications, experience distinct symptoms, or face unique risk factors that are not adequately addressed in the existing data.

One glaring area where data bias against women is evident is in reproductive health. The lack of comprehensive data on women’s reproductive systems can lead to suboptimal care and treatment options. From menstrual health to pregnancy complications, the absence of detailed data perpetuates stereotypes and neglects the diverse range of experiences women face in these areas. This oversight can hinder the development of personalized and effective healthcare solutions for women.

Data bias also affects the accuracy of diagnostic tools and models, as they may be trained on datasets that do not adequately represent the female population. This can result in misdiagnosis and delayed treatments, impacting women’s health outcomes. For example, cardiac diseases often present differently in women than in men, and relying on male-centric data can lead to underdiagnosis and substandard care for women.

To minimize this issue, it is important to prioritize inclusivity in medical research and data collection. Initiatives should be taken to ensure diverse representation in clinical trials and research studies. Healthcare professionals and researchers have to be mindful of the potential biases in their datasets and actively seek to address these gaps through targeted data collection efforts.

Data bias against women in healthcare is a pervasive issue that demands urgent attention. Closing the gender gap in medical research and data collection is not only essential for accurate diagnoses and effective treatments but is also a crucial step toward achieving gender equity in healthcare outcomes.

~ Written by Laasya Aki

References: